Can Treatment of Sudden Speech Impairment Be Life-Saving?
Rattachement africain : ch. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background/Purpose: Pediatric anti-NMDA receptor encephalitis is a rare and life-threatening disease. Timely diagnosis and treatment initiation directly influences outcome. Therefore, a high level of suspicion—particularly in mild new focal neurological deficits—is of utmost importance to prevent neurological sequelae. Case Presentation: We report on a 12.6-year-old female, who initially presented with two self-limiting focal seizures. Wake and sleep EEG were normal. Brain MRI revealed a leptomeningeal enhancement in the right central region. CSF showed a mild pleocytosis (total white blood cells 85/mm 3 ; lymphocytes 62/mm 3 ; monocytes 23/mm 3 ), pointing towards the diagnosis of viral meningitis. The patient recovered completely and control MRI of the brain 4 weeks later was normal. However, at that time she developed a sudden speech impairment with predominant dysarthria, headache, and tiredness. EEG was again unremarkable, ruling out nonconvulsive status epilepticus. Extensive laboratory workup revealed positive anti-NMDA receptor antibodies in CSF (1:10) and serum (1:10). After 1 g of intravenous methylprednisolone daily for 5 days, dysarthria improved significantly and complete recovery was documented within 4 weeks after symptom onset. The course of dysarthria is documented in a series of videos. Conclusion: Pediatric anti-NMDA receptor encephalitis can present with a wide spectrum of symptoms, resulting in a life threatening condition, if untreated. Diagnostic workup of rapid onset of speech dysfunction should include immediate testing of anti-NMDA-receptor antibodies in serum and CSF, as timely treatment initiation in this condition can be life-saving. Publication History Publication Date: 28 October 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Can Treatment of Sudden Speech Impairment Be Life-Saving?
- Date Crossref
- 28/10/2021
- Éditeur
- Georg Thieme Verlag KG
- Type
- proceedings-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.